Introduction {#section5-1756284819853115}
============

Barrett's esophagus (BE) is characterized by the replacement of the squamous epithelium with columnar epithelium in the distal esophagus.^[@bibr1-1756284819853115][@bibr2-1756284819853115]--[@bibr3-1756284819853115]^ It is a precancerous lesion with a 20--40-fold increased risk of esophageal adenocarcinoma (EAC), which has a poor prognosis with a 5-year survival rate of less than 15%.^[@bibr4-1756284819853115][@bibr5-1756284819853115]--[@bibr6-1756284819853115]^ In Western countries, the prevalence of BE and EAC has increased dramatically in recent decades.^[@bibr7-1756284819853115][@bibr8-1756284819853115]--[@bibr9-1756284819853115]^ Similar findings have also been observed in Asian countries.^[@bibr10-1756284819853115],[@bibr11-1756284819853115]^ A recent meta-analysis showed that the prevalence of histological BE increased from 0.8% (in 1991--1999) to 2.2% (in 2010--2014) in Asia and that Asian populations have the potential for cancerous progression from BE to EAC.^[@bibr11-1756284819853115]^ In addition, the proportion of the yield of histological BE increased with age. The upward trend reached a maximum value in the sixth decade of age and then maintained a plateau in the following decades.^[@bibr12-1756284819853115]^ However, the prevalence of BE in people younger than 50 years was variable (approximately 0.7--8.7%) according to previous studies.^[@bibr13-1756284819853115][@bibr14-1756284819853115]--[@bibr15-1756284819853115]^ Recently, the incidence of EAC has been reported to be increasing in those under 50 years of age.^[@bibr16-1756284819853115]^ Nevertheless, to date, BE-related risk factors in young adults remain inconclusive. It is difficult to provide information of risk stratification for BE screening in this population.

It is known that male sex, history of gastroesophageal reflux disease (GERD) symptoms, and smoking are regarded as risk factors of BE in aged patients.^[@bibr1-1756284819853115][@bibr2-1756284819853115]--[@bibr3-1756284819853115]^ The role of these risk factors in the development of BE in young adults remains unknown. In addition, central obesity and metabolic syndrome (MtS) were considered to be associated with BE.^[@bibr3-1756284819853115],[@bibr17-1756284819853115]^ However, several recent studies reported no association between central obesity and short-segment BE.^[@bibr18-1756284819853115][@bibr19-1756284819853115]--[@bibr20-1756284819853115]^ Specifically, short-segment BE represents the most common type of BE in Asia.^[@bibr2-1756284819853115]^ Moreover, most studies demonstrated that alcohol consumption does not increase the risk of BE.^[@bibr21-1756284819853115],[@bibr22-1756284819853115]^ However, two recent meta-analyses have revealed that alcohol consumption was positively associated with BE in Asian populations.^[@bibr23-1756284819853115],[@bibr24-1756284819853115]^ Owing to their potential to be modified and inconsistent evidence regarding the development of BE in Asian populations, all these factors require further investigation.

Consequently, we performed this retrospective study focusing on the population of young adults who underwent upper gastrointestinal endoscopy at a health examination center. We aimed to identify the risk factors of BE and to verify the impact of these potential risk factors on BE in young adults.

Materials and methods {#section6-1756284819853115}
=====================

Participants {#section7-1756284819853115}
------------

We reviewed 11,879 adults with or without symptoms who underwent upper gastrointestinal endoscopy at the health examination center of Kaohsiung Veterans General Hospital between January 2016 and December 2018. Among them, 1395 individuals underwent more than one round of upper gastrointestinal endoscopy during the study period. We selected the data of the round yielding histological BE or the data of the latest endoscopy if histological BE was not diagnosed during the study period. Among these individuals, we included participants (*n* = 5320) aged 20--49 years on the day of the visit. Participants with a history of esophageal cancer (*n* = 1) and with incomplete data in the questionnaire (*n* = 376) were excluded. Finally, 4943 individuals were enrolled ([Figure 1](#fig1-1756284819853115){ref-type="fig"}). The Ethics Committee of the Kaohsiung Veterans General Hospital (VGHKS18-CT11-03, VGHKS19-CT5-05) approved the study. The consent from the study participants was not required because the dataset consisted of de-identified data for research purposes.

![Flow chart of participants enrolled in the study.](10.1177_1756284819853115-fig1){#fig1-1756284819853115}

Data collection and measurement {#section8-1756284819853115}
-------------------------------

All the participants underwent biochemical and blood examinations before endoscopic examination. A questionnaire, including demographic data, past medical history, smoking details (number of packs, frequency, and duration),^[@bibr25-1756284819853115]^ alcohol intake (number, frequency, and alcohol percentage of drinks per week),^[@bibr26-1756284819853115]^ and GERD symptoms (heart burn, regurgitation, and dysphagia) in the previous 3 months was provided to all participants who underwent upper gastrointestinal endoscopy at our health examination center. The questionnaire was filled out by participants and then the data were recorded by one physician at our center during the pre-endoscopic examination interview. The body weight and height of all participants were measured using the electric impedance method analyzer (X-SCAN PLUS II, Jawon Medical, Seoul, South Korea). The body mass index (BMI) was calculated as weight (kg) divided by height (m) squared. Waist circumference (WC) (at the top of the iliac crests, standing position, with abdomen relaxed) of participants was measured by well-trained examiners. We obtained the definition of MtS from the International Diabetes Federation.^[@bibr27-1756284819853115]^ Individuals were defined as having MtS when they had central obesity (WC of ⩾ 90 cm for Chinese men and ⩾ 80 cm for Chinese women) and any two of the following characteristics: increased triglyceride level of ⩾ 1.69 mmol/L or treatment for lipid abnormality; reduced high-density lipoprotein cholesterol (\< 1.03 mmol/L in men, and \< 1.29 mmol/L in women) or treatment for lipid abnormality; treatment for previously diagnosed hypertension; elevated fasting plasma glucose level of ⩾ 5.60 mmol/L or previously diagnosed type 2 diabetes mellitus.

Endoscopy and biopsy {#section9-1756284819853115}
--------------------

The Evis Lucera Elite Video System (CLV-290 and CV-290, Olympus Medical, Tokyo, Japan) was used in conjunction with either the GIF-Q260, GIF-HQ290, or GIF-H290Z endoscopes with narrow-band images (Olympus Medical). Six experienced attending physicians performed the gastrointestinal endoscopy with the assistance of narrow-band images. In accordance with the Seattle protocol, biopsies were performed for the circumferential part of endoscopic-suspected esophageal metaplasia (ESEM).^[@bibr28-1756284819853115]^ Due to the lack of consensus on protocol for biopsies for noncircumferential ESEM, the physicians decided the sites and numbers of biopsies at mucosal tongues of noncircumferential ESEM (that is Prague C0Mx). All specimens were fixed in formalin for subsequent histological examinations. The definition of BE was based on the American College of Gastroenterology clinical guidelines.^[@bibr3-1756284819853115]^ BE was diagnosed based on the presence of salmon-colored mucosa in the tubular esophagus proximally extending up to 1 cm or more in the gastroesophageal junction with histological confirmation of intestinal metaplasia.^[@bibr3-1756284819853115]^ Short-segment BE was defined as less than 3 cm in length.^[@bibr2-1756284819853115]^

Statistical analysis {#section10-1756284819853115}
--------------------

We used SPSS, Version 20.0 (SPSS Inc., Armonk, NY, USA) to perform the statistical analyses. The included variables were: sex; age; presence of GERD symptoms (yes or no); history of smoking (yes or no); alcohol intake (heavy alcohol drinking was defined as 8 or more drinks a week for women and 15 or more drinks a week for men);^[@bibr26-1756284819853115]^ hyperuricemia (serum uric acid level ⩾ 0.41 mmol/L);^[@bibr29-1756284819853115]^ BMI; WC; MtS. Chi-square tests for categorical variables and independent *t* tests for continuous variables were used in the univariate analysis to evaluate the association between each variable and the prevalence of BE. Variables with a *p* value of \< 0.1 in the univariate analysis were assessed using a binary logistic regression analysis with a forward stepwise method used in the multivariate analysis. In addition, we assessed the effect of cumulative smoking (pack-years) on BE risk in a multivariate model. We considered a *p* value of \< 0.05 as statistically significant.

Results {#section11-1756284819853115}
=======

Of the 4943 participants, 88 (1.8 %) had BE. BE's mean length was 1.68 ± 0.89 cm. Short-segment BE accounted for 84.1% (74/88). The participants had a mean age of 40.5 years, and male participants comprised 51.4% of the study population. As shown in [Table 1](#table1-1756284819853115){ref-type="table"}, the participants with BE were older, predominantly men, and had a higher BMI and WC. In addition, the presence of GERD symptoms, history of smoking, heavy alcohol drinking, MtS, and hyperuricemia were more common in the population with BE than without. The unadjusted odds ratios (ORs) of the aforementioned factors are presented in [Table 2](#table2-1756284819853115){ref-type="table"}. Variables with a *p* value of \< 0.1 in the univariate analysis were examined using collinearity diagnostics. WC and BMI had collinearity. Therefore, we applied two models in the logistic regression analysis (presented as model 1a and model 1b in [Table 2](#table2-1756284819853115){ref-type="table"}). The two models showed the same results in that the following features were significantly associated with BE in young adults: male (adjusted OR: 2.03; 95% confidence interval \[CI\]: 1.20--3.45; *p* = 0.008); presence of GERD symptoms (adjusted OR: 2.06; 95% CI: 1.27--3.32; *p* = 0.003); history of smoking (adjusted OR: 2.19; 95% CI: 1.38--3.47; *p* = 0.001).

###### 

Demographic characteristics of participants with and without Barrett's esophagus.

![](10.1177_1756284819853115-table1)

  --------------------------------------------------------------------------------------
  Characteristics                                BE (−)\        BE (+)\      *p* value
                                                 *n* = 4855     *n* = 88     
  ---------------------------------------------- -------------- ------------ -----------
  Age (years)                                    40.5 ± 6.7     42.2 ± 6.2   0.019

  Sex                                                                        \< 0.001

   Male                                          2475 (49.0%)   66 (75.0%)   

   Female                                        2380 (51.0%)   22 (25.0%)   

  Presence of GERD symptoms                      672 (13.8%)    24 (27.3%)   \< 0.001

  History of smoking (yes)                       1331 (27.4%)   47 (53.4%)   \< 0.001

  Cumulative smoking (pack-years)                                            \< 0.001

   0                                             3524 (72.6%)   43 (46.6%)   

   \< 10                                         441 (9.1%)     8 (9.1%)     

   10--20                                        569 (11.7%)    17 (19.3%)   

   \> 20                                         321 (6.6%)     22 (25.0%)   

  Alcohol intake                                                             0.009

   No                                            1859 (38.3%)   25 (28.4%)   

   Yes, without heavy drinking                   2830 (58.2%)   55 (62.5%)   

   Yes, with heavy drinking                      169 (3.5%)     8 (9.1%)     

  BMI (kg/m^2^)                                  23.5 ± 3.8     24.3 ± 3.4   0.036

  WC (cm)                                        82.6 ± 10.3    86.0 ± 9.4   0.002

  MtS                                            744 (15.3%)    24 (27.3%)   0.002

  - WC (⩾ 90 cm for men, ⩾ 80 cm for women)      1809 (37.3%)   41 (46.6%)   

  - Type 2 DM or raised fasting plasma glucose   694 (14.3%)    19 (21.6%)   

  - Hypertension                                 320 (6.6%)     8 (9.1%)     

  - Reduced HDL cholesterol                      1606 (33.1%)   30 (34.1%)   

  - Raised triglycerides                         1345 (27.7%)   46 (52.3%)   

  Hyperuricemia (⩾ 0.41 mmol/L)                  1075 (22.1%)   32 (36.4%)   0.002
  --------------------------------------------------------------------------------------

BE, Barrett's esophagus; BMI, body mass index; DM, diabetes mellitus; GERD, gastroesophageal reflux disease; HDL, high-density lipoprotein; MtS, metabolic syndrome; WC, waist circumference.

###### 

Factors associated with Barrett' esophagus according to the univariate and multivariate binary logistic regression analyses.

![](10.1177_1756284819853115-table2)

  Characteristics                   Univariate analysis   Multivariate analysis                                                                                                                        
  --------------------------------- --------------------- ---------------------------------------------------------------- ------------------- ------- ------------------- ------- ------------------- ----------
  Age (years)                                             0.019[\*](#table-fn2-1756284819853115){ref-type="table-fn"}                                                                                  
  Sex                                                     \< 0.001[\*](#table-fn2-1756284819853115){ref-type="table-fn"}                       0.008                       0.008                       0.022
   Male                             2.89 (1.78--4.69)                                                                      2.03 (1.20--3.45)           2.03 (1.20--3.45)           1.89 (1.10--3.23)   
   Female                           1.0                                                                                    1.0                         1.0                         1.0                 
  Presence of GERD symptoms         2.33 (1.45--3.76)     \< 0.001[\*](#table-fn2-1756284819853115){ref-type="table-fn"}   2.06 (1.27--3.32)   0.003   2.06 (1.27--3.32)   0.003   2.03 (1.25--3.28)   0.004
  History of smoking (yes)          3.03(1.99--4.64)      \< 0.001[\*](#table-fn2-1756284819853115){ref-type="table-fn"}   2.19 (1.38--3.47)   0.001   2.19 (1.38--3.47)   0.001                       
  Cumulative smoking (pack-years)                         \< 0.001[\*](#table-fn2-1756284819853115){ref-type="table-fn"}                                                                               \< 0.001
   0                                1.0                                                                                                                                            1.0                 
   \< 10                            1.56 (0.73--3.35)     0.254                                                                                                                    1.23 (0.56--2.69)   0.602
   10--20                           2.57 (1.45--4.55)     0.001                                                                                                                    1.89 (1.03--3.46)   0.040
   \> 20                            5.89 (3.47--10.01)    \< 0.001                                                                                                                 4.09 (2.29--7.29)   \< 0.001
  Alcohol intake                                          0.009[\*](#table-fn2-1756284819853115){ref-type="table-fn"}                                                                                  
   No                               1.0                                                                                                                                                                
   Yes, without heavy drinking      1.45 (0.90--2.33)     0.129                                                                                                                                        
   Yes, with heavy drinking         3.52 (1.56--7.93)     0.002                                                                                                                                        
  BMI (kg/m^2^)                                           0.036[\*](#table-fn2-1756284819853115){ref-type="table-fn"}                                                                                  
  WC (cm)                                                 0.002[\*](#table-fn2-1756284819853115){ref-type="table-fn"}                                                                                  
  MtS (yes)                         2.07 (1.29--3.33)     0.002[\*](#table-fn2-1756284819853115){ref-type="table-fn"}                                                                                  
  Hyperuricemia (⩾ 0.41 mmol/L)     2.01 (1.30--3.12)     0.002[\*](#table-fn2-1756284819853115){ref-type="table-fn"}                                                                                  

Variables with *p* \< 0.1 were assessed using a binary logistic regression analysis.

Model 1a: adjusted for age, sex, presence of GERD symptoms, history of smoking, alcohol intake, WC, MtS, and hyperuricemia.

Model 1b: adjusted for age, sex, presence of GERD symptoms, history of smoking, alcohol intake, BMI, MtS, and hyperuricemia.

Model 2: adjusted for age, sex, presence of GERD symptoms, cumulative smoking, alcohol intake, WC, MtS, and hyperuricemia.

BMI, body mass index; CI, confidence interval; GERD, gastroesophageal reflux disease; OR, odds ratio; MtS, metabolic syndrome; WC, waist circumference.

In addition, we determined the relation between cumulative smoking (pack-years) and BE using a forward logistic regression model (presented as model 2 in [Table 2](#table2-1756284819853115){ref-type="table"}). Nonsmokers were used as the reference group. Participants who smoked 10--20 pack-years (adjusted OR: 1.89; 95% CI: 1.03--3.46; *p* = 0.040) and more than 20 pack-years (adjusted OR: 4.09; 95% CI: 2.29--7.29; *p* \< 0.001) had a significantly higher risk of BE, with the association strengthening with cumulative exposure to smoking (*p* trend \< 0.001).

We performed a subgroup analysis separated by sex. The prevalence of BE was 2.6% (66/2541) and 0.9% (22/2402) in male and female participants, respectively. In male participants, the following two factors were significantly associated with BE in the multivariate analysis: the presence of GERD symptoms (adjusted OR: 2.70; 95% CI: 1.60--4.55; *p* \< 0.001); cumulative smoking (adjusted OR: 4.27; 95% CI: 2.33--4.55; *p* \< 0.001 for \> 20 pack-years; adjusted OR: 2.12; 95% CI: 1.11--4.03; *p* = 0.022 for 10--20 pack-years; adjusted OR: 0.93; 95% CI: 0.35--2.49; *p* = 0.891 for \< 10 pack-years) ([Table 3](#table3-1756284819853115){ref-type="table"}). The proportion of BE in male participants with both GERD symptoms and a smoking history of 10 pack-years or more was 10.3% (16/155). In female participants, MtS was associated with BE after adjusting for WC or BMI (collinearity) and cumulative smoking (adjusted OR: 2.85; 95% CI: 1.04--7.79; *p* = 0.042) ([Table 4](#table4-1756284819853115){ref-type="table"}).

###### 

Factors associated with Barrett' esophagus in male participants.

![](10.1177_1756284819853115-table3)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristics                   BE (-)\      BE (+)\      Univariate analysis   Multivariate analysis                                                                
                                    *n* = 2475   *n* = 66                                                                                                                
  --------------------------------- ------------ ------------ --------------------- ---------------------------------------------------------------- ------------------- ----------
  Age (years)                       40.7 ± 6.8   42.9 ± 5.7                         0.003[\*](#table-fn7-1756284819853115){ref-type="table-fn"}                          

  Presence of GERD symptoms (yes)   382          23           2.93 (1.75--4.92)     \< 0.001[\*](#table-fn7-1756284819853115){ref-type="table-fn"}   2.70 (1.60--4.55)   \< 0.001

  Cumulative smoking (pack-years)                                                   \< 0.001[\*](#table-fn7-1756284819853115){ref-type="table-fn"}                       \< 0.001

   0                                1374         22           1.0                                                                                    1.0                 

   \< 10                            324          5            0.96 (0.36--2.56)     0.254                                                            0.93 (0.35--2.49)   0.891

   10--20                           476          17           2.23 (1.17--4.24)     0.001                                                            2.12 (1.11--4.03)   0.022

   \> 20                            301          22           4.57 (2.50--8.35)     \< 0.001                                                         4.27 (2.33--4.55)   \< 0.001

  Alcohol intake                                                                    0.120                                                                                

   No                               663          13           1.0                                                                                                        

   Yes, without heavy drinking      1653         45           1.39 (0.74--2.59)     0.302                                                                                

   Yes, with heavy drinking         159          8            2.57 (1.05--6.30)     0.040[\*](#table-fn7-1756284819853115){ref-type="table-fn"}                          

  BMI (kg/m^2^)                     25.0 ± 3.5   24.6 ± 3.1                         0.389                                                                                

  WC (cm)                           87.8 ± 9.2   87.9 ± 8.5                         0.885                                                                                

  MtS (yes)                         521          19           1.52 (0.88--2.61)     0.129                                                                                

  Hyperuricemia (⩾ 0.41 mmol/L)     1028         31           1.25 (0.76--2.04)     0.377                                                                                
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Variables with *p* \< 0.1 were assessed using a binary logistic regression analysis.

BE, Barrett's esophagus; BMI, body mass index; CI, confidence interval; GERD, gastroesophageal reflux disease; OR, odds ratio; MtS, metabolic syndrome; WC, waist circumference.

###### 

Factors associated with Barrett' esophagus in female participants.

![](10.1177_1756284819853115-table4)

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristics                   BE (-)\      BE (+)\      Univariate analysis   Multivariate analysis                                                                                         
                                    *n* = 2380   *n* = 22                                                                                                                                         
  --------------------------------- ------------ ------------ --------------------- ------------------------------------------------------------- ------------------- ------- ------------------- -------
  Age (years)                       40.7 ± 6.8   40.7 ± 6.8                         0.849                                                                                                         

  Presence of GERD symptoms (yes)   290          1            0.34 (0.05--2.56)     0.507                                                                                                         

  Cumulative smoking (pack-years)                                                   0.412                                                                                                         

   0                                2150         19           1.0                                                                                                                                 

   \< 10                            117          3            2.90 (0.85--9.94)     0.090[\*](#table-fn9-1756284819853115){ref-type="table-fn"}                                                   

   10--20                           93           0                                                                                                                                                

  \> 20                             20           0                                                                                                                                                

  Alcohol intake                                                                    0.930                                                                                                         

   No                               1196         12           1.0                                                                                                                                 

   Yes, without heavy drinking      1174         10           0.85 (3.65--1.97)     0.703                                                                                                         

   Yes, with heavy drinking         10           0                                                                                                                                                

  BMI (kg/m^2^)                     21.9 ± 3.5   23.5 ± 4.0                         0.035[\*](#table-fn9-1756284819853115){ref-type="table-fn"}                                                   

  WC (cm)                           77.3 ± 8.5   80.4 ± 9.8                         0.090[\*](#table-fn9-1756284819853115){ref-type="table-fn"}                                                   

  MtS (yes)                         223          5            2.85 (1.04--7.79)     0.051[\*](#table-fn9-1756284819853115){ref-type="table-fn"}   2.85 (1.04--7.79)   0.042   2.85 (1.04--7.79)   0.042

  Hyperuricemia (⩾ 0.41 mmol/L)     47           1            2.36 (0.31--17.94)    0.360                                                                                                         
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Variables with *p* \< 0.1 were assessed using a binary logistic regression analysis.

Model 1c: adjusted for cumulative smoking, WC, and MtS.

Model 1d: adjusted for cumulative smoking, BMI, and MtS.

BE, Barrett's esophagus; BMI, body mass index; CI, confidence interval; GERD, gastroesophageal reflux disease; OR, odds ratio; MtS, metabolic syndrome; WC, waist circumference.

Discussion {#section12-1756284819853115}
==========

There is a limited number of studies on BE in young adults. To our knowledge, this is the first large-scale retrospective cross-sectional study to determine the risk factors of BE in young adults and the first to evaluate the association between cumulative smoking (pack-years) and BE in an Asian population. In this study, the prevalence of BE in adults aged less than 50 years was 1.8%, which is slightly higher than that in other regions of Asia (0.7--1.1%).^[@bibr13-1756284819853115],[@bibr14-1756284819853115]^ However, the prevalence was still much lower than that in a European population (8.7%).^[@bibr15-1756284819853115]^ Ethnicity, differences in the study population, and different definitions of BE might be contributing factors for the differences.^[@bibr30-1756284819853115]^ In general, risk factors for BE were male sex, the presence of GERD symptoms, and smoking.^[@bibr1-1756284819853115][@bibr2-1756284819853115]--[@bibr3-1756284819853115]^ Such associations were also observed in young adults in the present study. Furthermore, consistent with earlier study results, we found that the association between BE and smoking strengthened with cumulative exposure to smoking.^[@bibr25-1756284819853115],[@bibr31-1756284819853115],[@bibr32-1756284819853115]^ However, the precise mechanism linking smoking and BE remains unclear. Recently, Kaz and colleagues reported an association between smoking and DNA methylation in the esophagus, increasing the risk of BE.^[@bibr33-1756284819853115]^ In addition mechanisms caused by smoking include stimulation of gastric acid secretion, decreased lower esophageal sphincter pressure, and impaired acid clearance from the esophagus.^[@bibr34-1756284819853115],[@bibr35-1756284819853115]^ Hence, future studies are needed to investigate the role of smoking on the mechanisms of BE development.

BMI was thought to be positively associated with BE.^[@bibr36-1756284819853115]^ However, in several recent studies, the correlation became weaker when simultaneously evaluating WC or waist-to-hip ratio, which are measures of central obesity.^[@bibr36-1756284819853115][@bibr37-1756284819853115]--[@bibr38-1756284819853115]^ A possible explanation is that the relation between central obesity and BE was independent of GERD symptoms and that central adiposity produces proinflammatory cytokines, which could cause inflammation and stimulate BE development.^[@bibr38-1756284819853115]^ However, we observed no significant associations between WC and BE in the present study. Ethnicity and the type of BE may be contributing factors. Kramer and colleagues revealed that the association between a high waist-to-hip ratio and BE was only observed in White men, not in Black or Hispanic men, and a high waist-to-hip ratio was not linked to an increased risk of short-segment BE.^[@bibr18-1756284819853115]^ Such findings were similar to our results because most participants (84.1%) in our study had short-segment BE. Short-segment BE represents the most common type of BE in Asia.^[@bibr2-1756284819853115]^ Hence, as shown in the additional studies performed in Japan and Taiwan, central obesity might be not a risk factor for BE.^[@bibr19-1756284819853115],[@bibr20-1756284819853115],[@bibr39-1756284819853115]^ Overall, these findings suggest the need to investigate the associations and mechanisms of BE, particularly in different races and types of BE, that are caused by central adiposity. On the other hand, similar to other studies, we also observed that alcohol consumption was not associated with BE.^[@bibr21-1756284819853115],[@bibr22-1756284819853115]^

Our findings demonstrated that the presence of GERD symptoms and smoking were significantly associated with BE in male participants. They also represented the risk factors of progression to EAC from BE.^[@bibr40-1756284819853115],[@bibr41-1756284819853115]^ The proportion of BE in male participants with both GERD symptoms and a smoking history of 10 pack-years or more was as high as 10.3% (16/155) in the present study. It could be considered to suggest endoscopic screening for BE in the group. MtS was linked with BE in female participants in our study. The association between MtS and BE had been previously reported.^[@bibr17-1756284819853115],[@bibr42-1756284819853115],[@bibr43-1756284819853115]^ The possible mechanism that was previously proposed was that increased levels of circulating proinflammatory cytokines, serum insulin, and insulin-like growth factors may play a role in BE pathogenesis.^[@bibr43-1756284819853115],[@bibr44-1756284819853115]^ However, the association between MtS and BE was not found in male participants. To our knowledge, literature assessing whether there is a gender difference in the association between BE and MtS is lacking. A previous study by Drahos and colleagues demonstrated that the association between MtS and esophageal adenocarcinoma was stronger in women (OR: 1.44; 95% CI: 1.20--1.73) than in men (OR: 1.09; 95% CI: 0.99--1.20).^[@bibr45-1756284819853115]^ Owing to the relatively fewer cases of BE in women in this study, we performed an analysis that enrolled individuals older than 50 years who underwent upper gastrointestinal endoscopy in our health examination center during the same study period ([Supplemental Figure 1](https://journals.sagepub.com/doi/suppl/10.1177/1756284819853115)). We used the same study methods to analyze this population. In the participants aged 50 years or older, the association between BE and MtS was also observed only in women, not in men ([Supplementary Tables 1--3](https://journals.sagepub.com/doi/suppl/10.1177/1756284819853115)). These results revealed that there is a gender difference in the association between BE and MtS regardless of age in the present study. However, why the association between MtS and BE was only noted in women remains unknown. BE is considered a chronic inflammatory condition. Rudnicka and colleagues reported that associations between inflammatory biomarkers and MtS were more obvious in women than in men.^[@bibr46-1756284819853115]^ Such findings may imply a gender difference in the MtS-induced inflammation. Further studies are necessary to clarify the association and mechanism between MtS and BE stratified by sex.

This study has some limitations. Being a retrospective cross-sectional study, there may be recall or information bias. For example, we did not have information on the duration and intensity of GERD symptoms, the previous history of BE, and medications history (such as proton-pump inhibitors, anti-reflux medicine, and medication with gastric irritants). Although the role of medical therapy on the regression of BE remains inconclusive,^[@bibr47-1756284819853115]^ the prevalence of GERD symptoms might be under- or overestimated. Furthermore, the number and location of endoscopic biopsies influence the detection rate of BE when performed by different physicians.^[@bibr48-1756284819853115]^ In this study, it is difficult to clarify the rate of accurate biopsy procedure. However, our well-experienced physicians assisted by narrow-band images could reduce the bias as much as possible. Moreover, there were relatively fewer cases of BE in women in the study, which may have failed to detect certain risk factors in this group; however, the data may demonstrate that the prevalence of BE in young women is very low.

Conclusion {#section13-1756284819853115}
==========

Significant risk factors of BE in young adults are male sex, the presence of GERD symptoms, and smoking. Furthermore, the risk of BE increases with an increase in cumulative exposure to smoking. We suggest young men with GERD symptoms and smoking history of 10 pack-years or more to consider endoscopic screening for BE. However, further studies on the progression from BE to cancer in this population and a cost-effectiveness analysis of endoscopic screening are necessary.
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